Rafa Laboratories
Prescription and Over-the-Counter Medicines
StartupRafa Laboratories is a Jerusalem-based startup in the Health Tech & Life Sciences sector, established in 1937. Prescription and Over-the-Counter Medicines. The company has 51-200 employees. Core technologies: Biologicals.
The company follows a B2B business model. Product stage: Released. The company holds 1 patent. Rafa Laboratories has been acquired.
- StageAcquired
- ProductReleased
- ModelB2B
- Employees51-200
- HQJerusalem
- DistrictJerusalem District
- StatusAcquired
- Last RoundUndisclosed
8 articles covered by sources including www.themarker.com,
www.prnewswire.com,
en.globes.co.il,
www.newswire.ca,
www.businesswire.com.
What does Rafa Laboratories do?
Rafa Laboratories is a pharmaceutical company that markets, manufactures, and distributes consumer health products and prescription and over-the-counter medicines, mainly proprietary formulations as well as generic formulations. The company manufactures a wide variety of medications based on in-house development and through external agreements. Rafa Laboratories is also involved in marketing drugs produced by international corporations such as Dr. Falk Pharma, Helsinn Healthcare, Boehringer Ingelheim, Purdue Pharma, 3M Healthcare, United Therapeutics, and Mundipharma. Rafa Laboratories received FDA approval for their 10 mg midazolam autoinjector, which can treat seizures caused by nerve agent exposure.
What sector is Rafa Laboratories in?
Rafa Laboratories operates in Health Tech & Life Sciences, Pharma & Medical Biotechnology, Drugs Discovery & Development, with core technologies in Biologicals. Target customers: Healthcare & Life Sciences, Life Sciences, Pharmaceuticals.
Where is Rafa Laboratories located?
Rafa Laboratories is based in Shlomo Momo ha-Levi St 5, Jerusalem, Israel, Jerusalem District.